Skip to main content

Table 2 MIDAS scores* at baseline, Week 12, and Week 104

From: Long-term reductions in disease impact in patients with chronic migraine following preventive treatment with eptinezumab

  

Baseline(n = 128)

Week 12 (n = 123)

Week 104 (n = 95)

Question A: On how many days in the last 3 months did you have a headache? (If a headache lasted more than 1 day, count each day.)

Mean

CFB

47.4

17.1

‒30.9

16.3

‒30.3

Question B: On a scale of 0–10, on average how painful were these headaches? (Where 0 = no pain at all, and 10 = pain as bad as it can be.)

Mean

CFB

7.3

5.5

‒1.8

4.5

‒2.8

Item 1: On how many days in the last 3 months did you miss work or school because of your headaches?

Mean

CFB

5.4

2.2

‒2.9

2.4

‒3.4

Item 2: How many days in the last 3 months was your productivity at work or school reduced by half or more because of your headaches? (Do not include days you counted in question 1 where you missed work or school.)

Mean

CFB

12.0

4.8

‒7.1

4.7

‒7.8

Item 3: On how many days in the last 3 months did you not do household work (such as housework, home repairs and maintenance, shopping, caring for children and relatives) because of your headaches?

Mean

CFB

15.6

4.7

‒10.9

5.8

‒10.2

Item 4: How many days in the last 3 months was your productivity in household work reduced by half or more because of your headaches? (Do not include days you counted in question 3 where you did not do household work.)

Mean

CFB

16.4

5.5

‒11.0

5.6

‒11.3

Item 5: On how many days in the last 3 months did you miss family, social or leisure activities because of your headaches?

Mean

CFB

8.0

2.8

‒5.0

3.6

‒4.8

  1. CFB Change from baseline, MIDAS Migraine Disability Assessment